Global Markets Direct: EpiCast Report: Human Immunodeficiency Virus - Epidemiology Forecast to 2022

This report provides an overview of the risk factors and global trends of HIV in seven major markets (the US, France, Germany, Italy, Spain, the UK, and Japan) in addition to emerging markets—Brazil, India, and China.
 
Feb. 19, 2013 - PRLog -- Although the number of HIV incident cases is expected to drop across the majority of Europe’s major nations in the near future, the UK figure will actually increase, predicts research and consulting firm.

According to the London based company’s new epidemiology report*, the number of newly diagnosed HIV cases in the UK is forecast to climb from 7,545 in 2012 to 8,691 by the end of 2022 – representing an increase of 15%.

The rise runs counter to forecasted trends for other major EU nations such as Germany, Italy, France and Spain, who can all expect falling incident cases of HIV during the same period.

Due primarily to substantial population growth within the 15–49 years age group, Our expects India to have the highest increase in HIV incident cases, with an increase of over 21,000 new cases expected over the 10 years.

For Sample Pages, please click or add the below link to your browser:

http://www.globalmarketsdirect.com/SamplePdfRequest.aspx?ID=Human-Immunodeficiency-Virus-Epidemiology-Forecast-to-2022&Title=Pharmaceuticals_and_Healthcare&ReportType=Industry_Report&CompanyID=prlog

Alyssa Klein, Our Senior Analyst covering Epidemiology, says: “If India and China adopt prevention programs similar to Brazil, which is often considered a model of HIV prevention for the developing world, the number of incident cases could decrease, as high-risk groups become the focus of targeted prevention strategies.”

Of the 10 markets studied in the report, Japan is expected to display the highest growth rate for the next decade. Although the country displayed the lowest number of HIV prevalent cases in 2012, with 1,327, this figure is forecast to climb by almost 40% to 1,854 by 2022.

This report provides an overview of the risk factors and global trends of HIV in seven major markets (the US, France, Germany, Italy, Spain, the UK, and Japan) in addition to emerging markets—Brazil, India, and China.

This report was built using data and information sourced from proprietary databases, primary and secondary research, and in-house analysis conducted by our team of industry experts.

Visit our Report Store

http://www.globalmarketsdirect.com

For more details contact:

pressreleases@globalmarketsdirect.com (mailto:pressreleases@globalmarketsdirect.com%20)
End
Source: » Follow
Email:***@globalmarketsdirect.com Email Verified
Zip:EC4Y 0AN
Tags:Global Markets Direct, Market Research, Pharma, EpiCast Report
Industry:Health
Location:London, Greater - England
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Global Markets Direct News
Trending
Most Viewed
Daily News



Like PRLog?
9K2K1K
Click to Share